Home > Financial Ratios > ASPIRA PATHLAB & DIAGNOSTICS

ASPIRA PATHLAB & DIAGNOSTICS
Core EBITDA Growth

    Back to All Ratios
ASPIRA PATHLAB & DIAGNOSTICS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ASPIRA PATHLAB & DIAGNOSTICS
Please provide your vote to see the results

ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024
   Core EBITDA Growth(%) 611.07-

What is the latest Core EBITDA Growth ratio of ASPIRA PATHLAB & DIAGNOSTICS ?

The latest Core EBITDA Growth ratio of ASPIRA PATHLAB & DIAGNOSTICS is 611.07 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025611.07
Mar2024-

How is Core EBITDA Growth of ASPIRA PATHLAB & DIAGNOSTICS Trending?

Years Core EBITDA Growth % Change
Mar2025 611.07
0
Mar2024 0 -

Other Financial Ratios of ASPIRA PATHLAB & DIAGNOSTICS


Compare Core EBITDA Growth ratio of peers of ASPIRA PATHLAB & DIAGNOSTICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASPIRA PATHLAB & DIAGNOSTICS ₹147.6 Cr 7.7% 56.7% 114.3% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹125,120.0 Cr -4% -1.6% 15.3% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹95,768.9 Cr -6.5% -2.9% -13.5% Stock Analytics
ASTER DM HEALTHCARE ₹64,094.1 Cr -3.3% -1.3% 17.4% Stock Analytics
FORTIS HEALTHCARE ₹61,831.1 Cr -8.1% -11.9% -14.1% Stock Analytics
NARAYANA HRUDAYALAYA ₹36,850.3 Cr -6.2% -6.7% 4.9% Stock Analytics


ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASPIRA PATHLAB & DIAGNOSTICS

7.7%

56.7%

114.3%

SENSEX

-2.7%

-5.7%

-11.7%


You may also like the below Video Courses